Litcius/Paper detail

Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit?

Cuicui Lu, Ning Hou

2020Frontiers in Pharmacology23 citationsDOIOpen Access PDF

Abstract

From mid-December 2019, the outbreak of the coronavirus disease 2019 in Wuhan has spread worldwide and become an emergency of major international concerns Recently, a television report has drawn extensive attention of the public in China. Two frontline doctors of the central hospital of Wuhan, Fan Yi and Weifeng Hu, were unfortunately infected by COVID-19. Cutaneous hyperpigmentation of the two doctors was noticed in the TV interview. Many people expressed grave concerns about the pathogenesis and prognosis of their skin pigmentary disorder.

Topics & Concepts

CulpritMedicineDermatologyCoronavirus disease 2019 (COVID-19)HyperpigmentationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusInflammationDiseaseVirologyInternal medicineInfectious disease (medical specialty)OutbreakMyocardial infarctionCOVID-19 Clinical Research StudiesDermatology and Skin DiseasesSARS-CoV-2 and COVID-19 Research